How many acquisitions has Amgen made so far?

Amgen has completed 27 acquisitions so far, with an average acquisition amount of $4.26B.

Which countries does Amgen usually acquire in?

Amgen has made acquisitions in 9 countries with the most activity in United States and Japan.

Which is Amgen's latest acquisition?

Amgen's most recent acquisition is Dark Blue Therapeutics, a Biotechnology company focused on drugs discovery services, acquired in January 2026.

Which sectors does Amgen target for acquisitions?

Most of Amgen's acquisitions are in Diversified Pharmaceuticals (6) and Immunotherapy (6).

In which year did Amgen make the most acquisitions?

Amgen was most active in 2012, with 5 acquisitions completed in that year.

List of 27 Acquisitions by Amgen (Nov 2026)

Most viewed in 2019

Amgen has made a total of 27 acquisitions. These activities spanned 17 sectors, including Oncology, Diversified Pharmaceuticals, and Immunotherapy, across nine countries, notably United States, Japan, and United Kingdom. Peak acquisition years included 2012 with 5 acquisitions, 2021 with 3, and 2022 with 2. The average number of acquisitions per year from 2020 to 2025 was 1, and the company completed 1 acquisition in the current calendar year. Its most recent acquisition, completed in January 2026, is Dark Blue Therapeutics, an Oxford-based biotechnology company founded in 2020 that specializes in drug discovery services.

Here's the year on year acquisition history of Amgen:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2022	2
2021	3
2020	1
2019	2
2017	2
2015	1
2013	1
2012	5
2011	1
2007	2
2006	1
2005	1
2004	1
2001	1
2000	1
1994	1

View all Acquisitions by Amgen

Recent acquisitions by Amgen

Amgen's most recent acquisition - Dark Blue Therapeutics is a Biotechnology company focused on drugs discovery services, founded in 2020 and located in Oxford. Amgen acquired it in January 2026 for a price of $*****.

Here is the list of all acquisitions by Amgen sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jan 06, 2026	Dark Blue Therapeutics	tbdz	piud	66	272
Dec 12, 2022	Horizon Therapeutics	duar	vvdu	46	307
Aug 04, 2022	ChemoCentryx	n{jo	hodf	15	746
Jul 27, 2021	TeneoBio	dfxl	ojsf	75	716
Mar 30, 2021	Rodeo Therapeutics	tqal	{hkp	86	813